Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation : macrophage-targeted steroid therapy
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-04-01
著者
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
MORI Shinichiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
MEGURO KUNIAKI
National Sendai Hospital
-
Minauchi Koichiro
Second Department Of Medicine Hokkaido University Graduate School Of Medicine
-
Naoe Tomoki
名古屋大学 医学系研究科血液・腫瘍内科学
-
MIYAMURA Koichi
Japanese Red Cross Nagoya First Hospital
-
Iino Masaki
Department Of Hematology Yamanashi Prefectural Central Hospital
-
Meguro Kuniaki
東北大学 医学部分子診断学
-
IWATO Koji
Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital
-
Ito Masafumi
Department Of Pathology Japanese Red Cross Nagoya First Hospital
-
Kato Tomonori
Department Of Functional Materials Science Faculty Of Engineering Saitama University
-
Miyamura Koichi
Department Of Hematology And Rheumatology Tohoku University Graduate School Of Medicine
-
Miyamoto Ken-ichi
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Naoe Tomoki
Department Of Hematologly And Oncology Nagoya University School Of Medicine
-
Miyamura Koichi
東北大学 医学系研究科血液・免疫病学分野
-
Miyazawa Keisuke
Department Of Hematology Tokyo Medical University
-
Murata Makoto
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
MATSUMOTO Kimikazu
Department of Pediatrics, Toyota Memorial Hospital
-
Nakayama Takayuki
Department Of Biological Sciences Graduate School Of Science And Technology Kumamoto University
-
Nishiwaki Satoshi
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Murata Makoto
Department Of Chemical Science And Engineering Graduate School Of Engineering Science Osaka Universi
-
Sugimoto Kyoko
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Ito Masafumi
Department Of Electrical And Electronic Engineering Faculty Of Science And Technology Meijo Universi
-
Naruse T
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Saito Shigeki
Department Of Hematology And Oncology Ja Aichi Showa Hospital
-
Goto Tatsunori
Department Of Bioscience And Bioinformatics Graduate School Of Computer Science And System Engineeri
-
Koyama Daisuke
Department Of Computer Science And Information Mathematics Faculty Of Electro-communications
-
Nishida Tetsuya
Department Of Bacteriology Hiroshima University Graduate School Of Biomedical Sciences
-
Nishida Tetsuya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Saito Shigeki
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Ozawa Yukiyasu
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Nakano Tatsunori
Second Departmant Of Medicine Nagoya City University Medical School
-
Miyazaki Koji
Department Of Hematology Kitasato University Hospital
-
Imahashi Nobuhiko
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
MIZUNO Hiroki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
SETO Aika
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
YOKOHATA Emi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
KUBOTA Naomi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
KAMOSHITA Sonoko
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
Seto Aika
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Yokohata Emi
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Mizuno Hiroki
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kamoshita Sonoko
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Imahashi Nobuhiko
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Ozawa Yukiyasu
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Goto Tatsunori
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Matsumoto Kimikazu
Department Of Pediatrics Japanese Red Cross Nagoya First Hospital
-
Koyama Daisuke
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Nishiwaki Satoshi
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kubota Naomi
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
IMAHASHI Nobuhiko
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
MATSUMOTO Kimikazu
Department of Hematology/Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital
関連論文
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Interlaboratory Comparison of Quantitative RT-PCR Based Detection for Minimal Residual Disease in Leukemias : A Standardization Approach in Japan
- Successful treatment of minimal residual disease-positive Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib followed by reduced-intensity unrelated cord blood transplantation after allogeneic peripheral blood stein cell transplan
- Prospective trial of high-dose chemotherapy followed by infusions of peripheral blood stem cells and dose-escalated donor lymphocytes for relapsed leukemia after allogeneic stem cell transplantation
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- PE-406 Relation of Body Mass Index to the Recurrence of Atrial Fibrillation after Pulmonary Vein Isolation via Radio Frequency Catheter Ablation(Diabetes/Obesity/Metabolic syndrome(07)(H),Poster Session(English),The 72nd Annual Scientific Meeting of the J
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Dose Modification of Imatinib by Monitoring the Level of BCR-ABL Transcript in Chronic Myelogenous Leukemia
- Imatinib Mesylate in Conjunction with Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Philadelphia Chromosome Positive Leukemias : Report of 4 Cases
- Detection of Clone-Specific Immunoglobulin Heavy Chain Genes in the Bone Marrow of B-cell-Lineage Lymphoma after Treatment
- High Expression of YB-1 Gene in Erythroid Cells in Patients with Refractory Anemia
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Donor cell leukemia after allogeneic peripheral blood stem cell transplantation : a case report and literature review
- Vagal Modification Can Also Help Prevent Late Recurrence of Atrial Fibrillation After Segmental Pulmonary Vein Isolation
- PJ-511 Preoperative eGFR and LVdP/dtmax Predict the Long-term Effectiveness of Cardiac Resynchronization Therapy(PJ086,Heart Failure (Treatment) 2 (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PJ-088 Optimization of Interventricular Delay in Cardiac Resynchronization Therapy Using Maximam LV dp/dt(PJ015,ICD (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy
- Mutational analysis of SOS1 gene in acute myeloid leukemia
- Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan
- Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
- Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
- Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia
- Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Successful Treatment with Imatinib Mesylate of a CML Patient in Megakaryoblastic Crisis with Severe Fibrosis
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- Safety and Efficacy of Autologous Progenitor Cell Transplantation for Therapeutic Angiogenesis in Patients With Critical Limb Ischemia
- Downregulation of microRNAs-143 and -145 in B-cell malignancies
- let-7 MicroRNA Functions as a Potential Growth Suppressor in Human Colon Cancer Cells(Molecular and Cell Biology)
- A Case of Interstitial Pneumonia Induced by Rituximab Therapy
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Chemical Speciation of Arsenic Species in Human Blood Serum by Liquid Chromatography Using a Phosphatidylcholine-Coated ODS Column with Detection by ICP-MS
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Establishment of a Stroma-Dependent Human Acute Myelomonocytic Leukemia Cell Line, NAMO-2, with FLT3 Tandem Duplication
- Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor : A Case Report and Review of the Literature
- High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
- Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
- A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura
- Interaction of von Willebrand Factor with the Extracellular Matrix and Glycocalicin under Static Conditions^1
- Fludarabine- and Cyclophosphamide-Based Nonmyelobalative Conditioning Regimen for Transplantation of Chronic Granulomatous Disease : Possible Correlation with Prolonged Pure Red Cell Aplasia
- Nucleotide Alteration of Retinoblastoma Protein-Interacting Zinc Finger Gene, RIZ, in Human Leukemia
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
- Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
- Spontaneous regression of aleukemic leukemia cutis harboring a NPM/RARA fusion gene in an infant with cutaneous mastosytosis
- A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade^【○!R】, ICL670) in patients with transfusion-dependent anemias and iron-overload : a Phase I study in Japan
- Biology, Clinical Relevance, and Molecularly Targeted Therapy in Acute Leukemia with FLT3 Mutation
- Nucleophosmin : A versatile molecule associated with hematological malignancies
- Mechanism-based Therapy for Leukemia: A Lesson from Atra Therapy
- Karyotypically independent clones with del(11q) and trisomy 10 in acute myeloid leukemia : trisomy 10 may appear as an additional change
- Antitumor effect of arsenic trioxide in murine xenograft model
- Successful Nonmyeloablative Bone Marrow Transplantation for Leukocyte Adhesion Deficiency Type I from an Unrelated Donor
- Significance of Decreased Plasma D-Dimer Levels following Lipopolysaccharide-Induced Disseminated Intravascular Coagulation in Rats
- Recombinant adeno-associated virus-mediated gene transfer into human leukemia cell lines
- Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
- Serologically HLA-DR-Mismatched Unrelated Donors Might Provide a Valuable Alternative in Allogeneic Transplantation : Experience from a Single Japanese Institution
- Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor
- Severe Hypercholesterolemia Associated with Decreased Hepatic Triglyceride Lipase Activity and Pseudohyponatremia in Patients after Allogeneic Stem Cell Transplantation
- Quality of Life in Adult Patients after Bone Marrow Transplantation
- Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rγc^ mice
- Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation
- Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
- CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy
- Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations
- Acute myeloid leukemia in the elderly : 159 Nagoya case studies
- Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines
- Toxic effects of arsenic (As^) and other metal ions on acute promelocytic leukemia cells
- Immunoglobulin Variable Region Structure and B-Cell Malignancies
- Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
- Immunoaffinity Purification and Characterization of CACGTG Sequence-Binding Proteins from Cultured Mammalian Cells Using an Anti c-Myc Monoclonal Antibody Recognizing the DNA-Binding Domain
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment
- Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
- Virus-Associated Hemophagocytic Syndrome Caused by Pandemic Swine-Origin Influenza A (H1N1) in a Patient After Unrelated Bone Marrow Transplantation
- Mismatched human leukocyte antigen class II-restricted CD8^+ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance : sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis
- Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients : a double-blind, randomized Phase III clinical trial
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Diagnosis of Intestinal Graft-versus-Host Disease and Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation
- Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation : macrophage-targeted steroid therapy
- Mutation of ARHGAP9 in patients with coronary spastic angina
- An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study
- Efficacy and safety of human adipose tissue-derived mesenchymal stem cells for supporting hematopoiesis
- Guest editorial : Introducing progress in hematology in this issue